Microba Life Sciences Ltd
ASX:MAP
Microba Life Sciences Ltd
Other Items
Microba Life Sciences Ltd
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Microba Life Sciences Ltd
ASX:MAP
|
Other Items
AU$65.8k
|
CAGR 3-Years
-22%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Other Items
-AU$666.7m
|
CAGR 3-Years
-116%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-4%
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Other Items
-AU$5.2m
|
CAGR 3-Years
43%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Other Items
-AU$484k
|
CAGR 3-Years
79%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Apiam Animal Health Ltd
ASX:AHX
|
Other Items
AU$554k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Healius Ltd
ASX:HLS
|
Other Items
AU$796.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
12%
|
CAGR 10-Years
28%
|
|
Microba Life Sciences Ltd
Glance View
Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm specializes in the analysis of gut microbiome and promotes development in pathology services, therapeutics and diagnostics based on the microbiome. The firm's flagship product is the Microba Insight, a sampling kit that allows the public to analyze personal gut microbiome. Its discovery platform uses human data and informatic approaches to connect microbial genotype to human phenotype. The company also offers support solutions to researchers.
See Also
What is Microba Life Sciences Ltd's Other Items?
Other Items
65.8k
AUD
Based on the financial report for Jun 30, 2025, Microba Life Sciences Ltd's Other Items amounts to 65.8k AUD.
What is Microba Life Sciences Ltd's Other Items growth rate?
Other Items CAGR 5Y
37%
The average annual Other Items growth rates for Microba Life Sciences Ltd have been -22% over the past three years , 37% over the past five years .
